Breastfeeding is the natural and golden standard for infant feeding as it has been proven to positively influence their development. Breast milk provides the ideal balance of nutrients for the infant and contains bioactive components. Human milk oligosaccharides (HMOs) are a crucial component of human milk and the third most abundant after lactose and lipids. They are a structurally and biologically diverse group of complex sugars. The composition of human milk oligosaccharides is individual to each mother and varies throughout lactation.
In this webinar, Lars Bode introduces HMOs, their beneficial roles in infant health and the potential outlook for HMOs in the future.
Prof. Lars Bode is Professor of Paediatrics in the Division of Neonatology and the Division of Gastroenterology, Hepatology and Nutrition, the Larsson-Rosenquist Chair of Collaborative Human Milk Research, and Director of the Larsson-Rosenquist Foundation Mother-Milk-Infant Centre of Research Excellence (MOMI CORE) at the University of California, San Diego. He has published over 120 peer-reviewed papers on HMOs and continues to lead international research in this specialised field.